ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,573Medicare Part D Prescriptions Filled, Including Refills

Rank: 250 out of 1000

$494K Total Retail Price of All Prescriptions

Rank: 260 out of 1000

420 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
32% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

18% of this provider’s 420 patients filled at least one prescription for a schedule three drug, compared to an average of 20%.

Risky Drugs to Seniors

3% of this provider’s 8,432 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
SIMVASTATIN 494 389 1 3
LISINOPRIL 400 343 2 5
OMEPRAZOLE 390 347 3 2
MELOXICAM 384 290 4 14
FUROSEMIDE 381 267 5 7
ZOLPIDEM TARTRATE 332 261 6 16
METFORMIN HCL 259 204 7 8
LEVOTHYROXINE SODIUM 253 229 8 4
AMLODIPINE BESYLATE 243 217 9 6
HYDROCODONE-ACETAMINOPHEN 216 161 S3 10 1
ATENOLOL 212 178 11 24
HYDROCHLOROTHIAZIDE 208 165 12 9
LOSARTAN POTASSIUM 205 159 13 25
NEXIUM 192 143 14 23
TAMSULOSIN HCL 185 170 15 33
AZITHROMYCIN 168 131 16 36
TRAMADOL HCL 138 108 17 13
GLIMEPIRIDE 130 104 18 34
BISOPROLOL-HYDROCHLOROTHIAZIDE 128 108 19 101
METOPROLOL TARTRATE 121 107 20 19
POTASSIUM CHLORIDE 115 89 21 10
AMLODIPINE BESYLATE-BENAZEPRIL 114 112 22 59
DONEPEZIL HCL 114 101 22 32
METOPROLOL SUCCINATE 108 93 24 21
RAMIPRIL 107 93 25 77
KLOR-CON 8 106 88 26 217
DIOVAN 102 78 27 67
CYCLOBENZAPRINE HCL 90 55 R 28 39
FLUOXETINE HCL 89 59 29 51
CITALOPRAM HBR 86 56 30 17
PANTOPRAZOLE SODIUM 79 50 31 28
JANUVIA 77 62 32 85
ALLOPURINOL 76 70 33 31
SERTRALINE HCL 75 64 34 26
LISINOPRIL-HYDROCHLOROTHIAZIDE 74 58 35 20
CARVEDILOL 73 62 36 15
LEVEMIR FLEXPEN 70 44 37 205
CLOPIDOGREL 69 54 38 35
DIGOXIN 67 67 39 52
PROAIR HFA 66 61 40 50
SYNTHROID 63 60 41 91
NABUMETONE 63 36 41 169
CRESTOR 62 51 43 30
SPIRIVA 59 58 44 64
ESCITALOPRAM OXALATE 58 39 45 60
PRAVASTATIN SODIUM 56 48 46 12
PREDNISONE 54 50 47 42
PAROXETINE HCL 54 36 47 63
AMOXICILLIN 53 41 49 89
TERAZOSIN HCL 51 39 50 150
GABAPENTIN 50 38 51 11
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.